NO890174L - Rekombinante interleukin-1alfa-polypeptider. - Google Patents

Rekombinante interleukin-1alfa-polypeptider.

Info

Publication number
NO890174L
NO890174L NO89890174A NO890174A NO890174L NO 890174 L NO890174 L NO 890174L NO 89890174 A NO89890174 A NO 89890174A NO 890174 A NO890174 A NO 890174A NO 890174 L NO890174 L NO 890174L
Authority
NO
Norway
Prior art keywords
polypeptides
1alfa
dna sequences
recombinant interleukin
recombinant vectors
Prior art date
Application number
NO89890174A
Other languages
English (en)
Norwegian (no)
Other versions
NO890174D0 (no
Inventor
Peter T Lomedico
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO890174D0 publication Critical patent/NO890174D0/no
Publication of NO890174L publication Critical patent/NO890174L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO89890174A 1988-01-15 1989-01-13 Rekombinante interleukin-1alfa-polypeptider. NO890174L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14445788A 1988-01-15 1988-01-15

Publications (2)

Publication Number Publication Date
NO890174D0 NO890174D0 (no) 1989-01-13
NO890174L true NO890174L (no) 1989-07-17

Family

ID=22508674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890174A NO890174L (no) 1988-01-15 1989-01-13 Rekombinante interleukin-1alfa-polypeptider.

Country Status (19)

Country Link
EP (1) EP0324447B1 (da)
JP (1) JP2567079B2 (da)
AR (1) AR245958A1 (da)
AT (1) ATE142696T1 (da)
AU (1) AU616461B2 (da)
DE (1) DE58909723D1 (da)
DK (1) DK16489A (da)
ES (1) ES2091752T3 (da)
FI (1) FI890175A (da)
GR (1) GR3021887T3 (da)
HU (1) HU208996B (da)
IE (1) IE890087L (da)
IL (1) IL88934A (da)
MC (1) MC2002A1 (da)
NO (1) NO890174L (da)
NZ (1) NZ227594A (da)
PT (1) PT89438B (da)
YU (1) YU6889A (da)
ZA (1) ZA89202B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
DE3818660A1 (de) * 1987-06-05 1988-12-15 Colgate Palmolive Co Freifliessendes, pulvriges geschirrwaschmittel und verfahren zur herstellung desselben
DK172424B1 (da) * 1988-07-29 1998-06-08 Otsuka Pharma Co Ltd IL-1alfa-Derivater, farmaceutisk præparat omfattende sådanne derivater, anvendelse af IL-1alfa-derivater, DNA sekvenser kod
US7176179B1 (en) 1997-05-30 2007-02-13 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US6191269B1 (en) 1997-05-30 2001-02-20 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US20030154504A1 (en) 1998-06-24 2003-08-14 Farese Robert V. Methods and compositions for modulating carbohydrate metabolism
DE10252634A1 (de) * 2002-11-11 2004-05-27 Umwelttechnik Georg Fritzmeier Gmbh & Co. Reinigungsmittel und Verfahren zu seiner Herstellung
EP2464330B1 (en) * 2009-09-29 2016-03-23 United Technologies UT AG Oral care compositions containing human recombinant interleukin-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188920B1 (en) * 1984-12-25 1993-09-29 Dainippon Pharmaceutical Co., Ltd. Interleukin 1 and its derivative
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
DE3515217A1 (de) * 1985-04-26 1986-10-30 Siemens AG, 1000 Berlin und 8000 München Vorrichtung zur messung schwacher magnetfelder
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha

Also Published As

Publication number Publication date
DE58909723D1 (de) 1996-10-17
EP0324447A3 (de) 1990-01-31
YU6889A (en) 1990-08-31
AU616461B2 (en) 1991-10-31
AR245958A1 (es) 1994-03-30
DK16489D0 (da) 1989-01-13
EP0324447A2 (de) 1989-07-19
HUT50505A (en) 1990-02-28
AU2850989A (en) 1989-07-20
ATE142696T1 (de) 1996-09-15
PT89438A (pt) 1990-02-08
ZA89202B (en) 1989-09-27
JPH025892A (ja) 1990-01-10
GR3021887T3 (en) 1997-03-31
ES2091752T3 (es) 1996-11-16
IE890087L (en) 1989-07-15
FI890175A0 (fi) 1989-01-13
IL88934A0 (en) 1989-08-15
HU208996B (en) 1994-09-28
PT89438B (pt) 1993-09-30
MC2002A1 (fr) 1990-01-26
FI890175A (fi) 1989-07-16
NZ227594A (en) 1991-09-25
NO890174D0 (no) 1989-01-13
IL88934A (en) 1994-05-30
DK16489A (da) 1989-07-16
JP2567079B2 (ja) 1996-12-25
EP0324447B1 (de) 1996-09-11

Similar Documents

Publication Publication Date Title
NZ223506A (en) Tissue factor protein, dna encoding it, vectors, host cells, production of the protein and pharmaceutical compositions
DE69428214T2 (de) Transformierender wachstumsfaktor alpha h1
ZA91134B (en) New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses
IL99401A0 (en) Nucleotide sequence coding for an outer membrane protein and use of said protein in vaccine preparations
ZA943464B (en) Vascular endothelial growth factor 2
ATE255128T1 (de) Peptid-immitierende substanzen in der krebstherapie
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
BG62870B1 (bg) Метод за получаване на човешка дезоксирибонуклеаза
NO177678C (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
AU1724795A (en) Human tissue inhibitor of metalloproteinase-4
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
NO890174L (no) Rekombinante interleukin-1alfa-polypeptider.
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
DK288789D0 (da) Peptider og syreadditionssalte deraf, deres fremstilling og anvendelse
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
LV11803A (lv) Nesplaisinga gp350/220 varianti
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
SG128403A1 (en) Tnf-receptors, tnf binding proteins and dnas coding for them
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
ATE6639T1 (de) Ein gereinigtes polypeptid, ein verfahren zu dessen herstellung, dessen anwendung und das enthaltende pharmazeutische praeparat.
ATE98990T1 (de) Menschlicher prourokinase aehnliches polypeptid.
DK575287D0 (da) Anvendelse af vaevsfaktorprotein og antagonister herfor til fremstilling af laegemidler til behandling af bloedningsforstyrrelser samt farmaceutiske praeparater indeholdende disse